RxDoctor Payments Data

James Thornburgh, MD

Psychiatry · Alexandria, VANPI 1043387236

Payments from drug & device makers

$1,356in general payments, 2019–2025

Across 71 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$426
  • AbbVie$188
  • Vanda Pharmaceuticals Inc.$168
  • Sunovion Pharmaceuticals Inc.$126
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$106
  • Alkermes, Inc.$88
  • plus $254 from 5 others

What the payments were for

  • Food & beverage$1,32698%
  • Education$302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,356 in reported general payments places this provider in the 75th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$12,565
Medicare patients
16
Services billed
121

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate63$173,127
Abilify MaintenaAripiprazole15$41,595
Risperdal ConstaRisperidone Microspheres21$36,582
Fluphenazine Decanoate27$3,563
Paliperidone ErPaliperidone59$2,839
Olanzapine191$2,728
Quetiapine Fumarate83$1,466
Clozapine15$1,371
Divalproex Sodium ErDivalproex Sodium17$1,350
Haloperidol Decanoate16$1,183
Aripiprazole31$1,179
Trifluoperazine Hcl14$939
Olanzapine OdtOlanzapine12$843
Bupropion XlBupropion Hcl67$678
Risperidone58$562

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$54$209,70884 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$74$41,59515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →